Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With An Eye On Diversity, FDA Recognizes MedTech Color Collaborative Community

Executive Summary

The new collaborative community from MedTech Color – the 11th that the US FDA has formally recognized – will push for better representation for people of color in clinical studies and other product development activities.

You may also be interested in...



Leveling The Playing Field: Edwards Dedicates $100M To Racial Equity

The fund will support financial institutions in underserved communities and promote an economic cycle focused on creating jobs.

A Helping Hand: 'MedTech Color' Aims To Move Minorities From Shop Floor To Executive Suite

Industry veteran Kwame Ulmer has cobbled together a new group to help address perceived racial disparities at device firms. "MedTech Color" has already attracted attention from heavy-hitters Johnson & Johnson, Medtronic, 3M and Danaher, as well as industry advocacy group AdvaMed.

Speaking Of Medtech, Ep. 10: FDA’s TAP Pilot

In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT143982

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel